Post-Treatment PET/CT Dosimetry to Predict Contralateral Lobe Hypertrophy After Transarterial Radioembolization for Hepatocellular Carcinoma
Post-TARE ⁹⁰Y PET/CT dosimetry, particularly in combination with platelet count, is an effective approach to predict contralateral hypertrophy in treatment-naïve patients with HCC. Further studies with larger prospective cohorts are required to validate these predictive strategies.
Authors
- Minseok Suh (ORCID: https://orcid.org/0000-0002-6932-8552)
- Jin Woo Choi (ORCID: https://orcid.org/0000-0002-6639-8002)
- Hyo‐Cheol Kim (ORCID: https://orcid.org/0000-0002-6016-247X)
- Jin Chul Paeng (ORCID: https://orcid.org/0000-0002-7464-9342)
- Yeon-koo Kang (ORCID: https://orcid.org/0000-0001-6001-2140)
Institutions
- Seoul National University (KR)
- Seoul National University Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Korean Journal of Radiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3348/kjr.2025.0867
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00